Product

Company

NCT01186185·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Oregon Health and Science University

Age

18–89

Sex

ALL

Healthy volunteers

Not accepted

Age 18 or older
Idiopathic sudden sensorineural hearing loss within 3 months
Failure to recover hearing with glucocorticoid treatment or inability to tolerate glucocorticoid

Other diagnosis for the sudden hearing loss
Concurrent systemic use of another steroid
Hypersensitivity to fludrocortisone
Systemic fungal infection
Hypertension requiring two or more medications
Pitting edema
Cardiomegaly
Congestive heart failure
Electrolyte abnormality
Concurrent use of barbiturates, phenytoin, fosphenytoin, rifampin, or rifapentine

The record

StatusTerminated

PhaseEarly phase 1

Taking part5

StartedAug 2012

UpdatedOct 18, 2019

Conditions

Where1

Clareo Health | Fludrocortisone for Sudden Hearing Loss